Archives

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center 150 150 Shields Health Solutions

Pandemic Management Strategies for Patients With Cancer at an Academic Medical Center

By Martha Stutsky, PharmD, BCPS; and Osama Abdelghany, PharmD, MHA, BCOP Smilow Cancer Hospital at Yale New Haven Health System in Connecticut is 1 of 45 National Cancer Institute–designated comprehensive…

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective 150 150 Shields Health Solutions

COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspective

By Claudia S. Castro, PharmD, MS, BCOP, BCGP; and Amanda Manoogian, PharmD, BCOP The prevalence of individuals living with cancer continues to rise, largely because of an aging and growing…

ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit 204 115 Shields Health Solutions

ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit

Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Complex Patient Data Platform Drives Business Intelligence 1024 576 Shields Health Solutions

Complex Patient Data Platform Drives Business Intelligence

By Troy Polan, Acting CEO and CTO Sophisticated data capabilities set Excelera apart. Our Complex Patient Data Platform supports dashboards of critical as well as supplementary data for each health…

COVID & Oncology – The Effects on Health System Specialty Pharmacies 1024 791 Shields Health Solutions

COVID & Oncology – The Effects on Health System Specialty Pharmacies

This blog was written by Excelera, a Shields company. Two months ago, our blog discussed the potential impacts and areas of concern for health system specialty pharmacies and COVID. However,…

Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Network 204 115 Shields Health Solutions

Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Network

Orlando Health is the first health system in Florida to partner with Excelera®, the company behind the Excelera Network, to further optimize its specialty pharmacy services and to provide patients with increased access to limited distribution drugs (LDDs), which include innovative oncology treatments.
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19 150 150 Shields Health Solutions

Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19

By Vinay Sawant, RPh, MPH, MBA; Ayse Hursid, PharmD; Osama Abdelghany, PharmD, MHA, BCOP; and Terri Sue Bukowski, PharmD, CSP The coronavirus disease 2019 (COVID-19) pandemic has resulted in rewriting…

Excelera® and Aptitude Health Partner to Improve Oncology Patient Outcomes Through Combined Clinical Knowledge and Education 204 115 Shields Health Solutions

Excelera® and Aptitude Health Partner to Improve Oncology Patient Outcomes Through Combined Clinical Knowledge and Education

Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
COVID — Potential Impact on PBMS and Payers 1024 152 Shields Health Solutions

COVID — Potential Impact on PBMS and Payers

Most Americans seem to be moving on from initial COVID-19 panic, and we are seeing states follow suit by systematically putting plans in place to open back up. This post-pandemic…

COVID – Potential Impact on Health System Specialty Pharmacies 1024 152 Shields Health Solutions

COVID – Potential Impact on Health System Specialty Pharmacies

COVID-19 has altered life as we know it, including health care, across the United States. Impacts are likely to be seen in pharmacy across various business units, due to changes…